Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06622941
PHASE2

Study to ONO-4538 in Patients With Rhabdoid Tumor

Sponsor: Ono Pharmaceutical Co. Ltd

View on ClinicalTrials.gov

Summary

Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors

Official title: A Multicenter, Open-label, Uncontrolled Phase II Study to Investigate Efficacy and Safety of ONO4538 in Patients With Rhabdoid Tumor

Key Details

Gender

All

Age Range

1 Year - Any

Study Type

INTERVENTIONAL

Enrollment

23

Start Date

2024-11-25

Completion Date

2030-03-31

Last Updated

2026-03-12

Healthy Volunteers

No

Conditions

Interventions

DRUG

ONO-4538

every 2 weeks

Locations (5)

Nagoya University Hospital

Nagoya, Aichi-ken, Japan

Hokkaido University Hospital

Sapporo, Hokkaido, Japan

Hyogo Prefectural Kobe Children's Hospital

Kobe, Hyōgo, Japan

Osaka City General Hospital

Osaka, Osaka, Japan

National Cancer Center Hospital

Chuo-ku, Tokyo, Japan